File Download
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Targeting GRB7/ERK/FOXM1 signaling cascade is a promising therapeutic approach in ovarian cancer
| Title | Targeting GRB7/ERK/FOXM1 signaling cascade is a promising therapeutic approach in ovarian cancer |
|---|---|
| Authors | |
| Issue Date | 2012 |
| Publisher | American Association for Cancer Research. |
| Citation | The 103rd Annual Meeting of the American Association for Cancer Research (AACR 2012), Chicago, IL., 31 March-4 April 2012. How to Cite? |
| Abstract | Ovarian cancer is a higly mortal disease with poor prognosis and especially in high grade tumor. Emerging evidence has reported that aberrant upregulation and activation of GRB7, ERK as well as FOXM1 are closely associated with aggresivenesss of human cancers. However, the interplay between these factors in the pathogenesis of human cancers remains unclear. In this study, we found that ... |
| Description | Poster Session 6 - GTPases and Effectors: abstract no. 2159 |
| Persistent Identifier | http://hdl.handle.net/10722/149292 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chan, DW | en_US |
| dc.contributor.author | Ngan, HYS | en_US |
| dc.date.accessioned | 2012-06-22T06:35:12Z | - |
| dc.date.available | 2012-06-22T06:35:12Z | - |
| dc.date.issued | 2012 | en_US |
| dc.identifier.citation | The 103rd Annual Meeting of the American Association for Cancer Research (AACR 2012), Chicago, IL., 31 March-4 April 2012. | en_US |
| dc.identifier.uri | http://hdl.handle.net/10722/149292 | - |
| dc.description | Poster Session 6 - GTPases and Effectors: abstract no. 2159 | - |
| dc.description.abstract | Ovarian cancer is a higly mortal disease with poor prognosis and especially in high grade tumor. Emerging evidence has reported that aberrant upregulation and activation of GRB7, ERK as well as FOXM1 are closely associated with aggresivenesss of human cancers. However, the interplay between these factors in the pathogenesis of human cancers remains unclear. In this study, we found that ... | - |
| dc.language | eng | en_US |
| dc.publisher | American Association for Cancer Research. | - |
| dc.relation.ispartof | Annual Meeting of the American Association for Cancer Research, AACR 2012 | en_US |
| dc.title | Targeting GRB7/ERK/FOXM1 signaling cascade is a promising therapeutic approach in ovarian cancer | en_US |
| dc.type | Conference_Paper | en_US |
| dc.identifier.email | Chan, DW: dwchan@hku.hk | en_US |
| dc.identifier.email | Ngan, HYS: hysngan@hkucc.hku.hk | en_US |
| dc.identifier.authority | Chan, DW=rp00543 | en_US |
| dc.identifier.authority | Ngan, HYS=rp00346 | en_US |
| dc.description.nature | link_to_OA_fulltext | - |
| dc.identifier.hkuros | 199849 | en_US |
| dc.publisher.place | United States | - |
| dc.description.other | The 103rd Annual Meeting of the American Association for Cancer Research (AACR 2012), Chicago, IL., 31 March-4 April 2012. | - |